Matthew Might

Matthew Might, Ph.D., a strategic leader appointed to the White House Precision Medicine Initiative by former President Barack Obama, has been named the inaugural director of the Hugh Kaul Personalized Medicine Institute at the University of Alabama at Birmingham School of Medicine.

Might comes to UAB from the University of Utah, where he is a Presidential Scholar and an associate professor in both computer science and pharmaceutical chemistry, and from Harvard Medical School, where he is a visiting professor of biomedical informatics. Might’s research interests focus on the intersection of computation and medicine to advance precision medicine through personalized therapeutics.

Precision medicine is an emerging practice of conducting medicine that uses a comprehensive set of resources and information — from an individual’s family history and genetic profile to lifestyle and environment — in order to guide decisions for the prevention, diagnosis and treatment of disease. It has attracted significant early attention for its promise in treating rare diseases and cancers at their root cause. The Hugh Kaul Personalized Medicine Institute, named by a gift from the Hugh Kaul Foundation, was established in 2014. Might will be the inaugural director of the institute.

Research and Teaching Interests:

• Precision medicine, biomedical informatics